CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue
Research and development services	€ 3	€ 0
Advisory services	0	3
Grants revenue	274	482
Total Revenues	277	485
Expenses
Research and development	599	582
General and administrative	879	332
Total Expenses	1,478	914
Operating Loss	(1,201)	(429)
Interest expense	697	694
Other expense	37	88
Loss before income tax provision	(1,861)	(1,211)
Income tax provision	0	0
Net Loss	(1,861)	(1,211)
Other comprehensive loss
Foreign currency translation adjustment	0	7
Comprehensive loss	€ (1,861)	€ (1,204)
Basic and diluted earnings per share	€ (0.00)	€ (0.00)
Weighted-average shares outstanding, basic and diluted	303,757,622	303,757,622